AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 6,490.00
+190.00 (3.02%)
May 21, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 182.33 billion as of May 21, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
182.33B
Enterprise Value
169.56B
Revenue
3.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,490.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 182.33B, a decrease of -56.93%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 182.33B | -27.46% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 200.66B |
| Whan In Pharm | 200.18B |
| Daewon Pharmaceutical | 199.55B |
| Jeil Pharmaceutical Co.,Ltd | 188.70B |
| HLB Pharmaceutical | 182.55B |
| JW Lifescience | 181.01B |
| Hana Pharm | 174.71B |
| Ilyang Pharmaceutical Co.,Ltd | 172.08B |